Research & Innovation
The science of longevity
is our life's work.
Metamed is committed to advancing the science of metabolic health through clinical research, outcomes tracking, and partnerships with leading medical institutions.
Where Metamed is
pushing the frontier.
Metabolic Phenotyping
Developing precision biomarker protocols to identify metabolic subtypes — enabling hyper-personalized treatment before symptoms appear. Our approach goes beyond BMI to understand body composition, hormonal profile, and mitochondrial function.
AI-Driven Outcomes Research
Leveraging MetAi's anonymized data to study what treatment combinations produce the best long-term outcomes — contributing to a growing body of real-world evidence in metabolic medicine.
Longevity Biomarkers
Researching the optimal biomarker panel for predicting and measuring longevity outcomes — including inflammatory markers, telomere-associated proteins, and advanced lipid panels beyond standard clinical guidelines.
Cardiovascular Risk Prevention
Building evidence for early intervention in cardiovascular risk — studying how metabolic health optimization reduces cardiac events over 5, 10, and 20-year horizons in previously high-risk populations.
Behavioural Science Integration
Studying the intersection of psychology and metabolic health — contributing to evidence on how behavioural interventions produce measurable changes in hormonal profiles, gut microbiome, and metabolic rate.
Digital Health Efficacy
Measuring the clinical impact of AI-powered health monitoring — including MetaLens food recognition accuracy, wearable-derived insights, and real-time physician feedback on patient outcomes.
Building the global evidence base
for metabolic longevity.
Metamed is actively developing partnerships with academic medical centers, research hospitals, and longevity science institutions across Canada and internationally.
Our clinical outcomes data — representing thousands of patient-months of physician-supervised metabolic treatment — positions Metamed as a meaningful contributor to the global evidence base. We believe the next decade of longevity medicine will be written by clinics like ours.
Interested in Partnership?
Collaborate with
Metamed Research.
Academic institutions, research hospitals, and innovation partners — we want to hear from you.